Cocrystal Pharma (COCP) Amortization of Deferred Charges (2011 - 2026)
Cocrystal Pharma (COCP) reported Amortization of Deferred Charges of $79000.0 for Q1 2026, up 6.76% on a YoY basis from $74000.0 in Q1 2025, and up 6.76% sequentially from $74000.0 in Q1 2025.
Cocrystal Pharma (COCP) Amortization of Deferred Charges (2011 - 2026) Analysis & Trends
Cocrystal Pharma (COCP) has 8 years of Amortization of Deferred Charges data on file, last reported at $79000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization of Deferred Charges rose 6.76% year-over-year to $79000.0; the trailing twelve-month figure through Mar 2026 stood at $262000.0 (up 10.55% YoY), and the FY2012 full-year result was $36304.0, down 77.37% from the prior year.
- Amortization of Deferred Charges rose to $79000.0 in Q1 2026, from $74000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $79000.0 in Q1 2026 to a low of $49000.0 in Q1 2022.
- A 4-year average of $58375.0 and a median of $54000.0 in 2023 frame the typical range for Amortization of Deferred Charges.
- Across the five-year window, Amortization of Deferred Charges increased 4.26% in 2022 and gained 10.2% in 2023, its largest moves.
- Tracing COCP's Amortization of Deferred Charges over 4 years: stood at $51000.0 in 2022, then advanced by 7.84% to $55000.0 in 2023, then soared by 34.55% to $74000.0 in 2025, then increased by 6.76% to $79000.0 in 2026.
- Business Quant data shows COCP's Amortization of Deferred Charges at $79000.0 in Q1 2026, $74000.0 in Q1 2025, and $55000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79,000.00 |
| Mar 31, 2026 | 79,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Sep 30, 2023 | 55,000.00 |
| Sep 30, 2023 | 55,000.00 |
| Jun 30, 2023 | 54,000.00 |
| Jun 30, 2023 | 54,000.00 |
| Mar 31, 2023 | 54,000.00 |
| Mar 31, 2023 | 54,000.00 |
| Sep 30, 2022 | 51,000.00 |
| Sep 30, 2022 | 51,000.00 |
| Jun 30, 2022 | 51,000.00 |
| Jun 30, 2022 | 51,000.00 |
| Mar 31, 2022 | 49,000.00 |
| Mar 31, 2022 | 49,000.00 |
| Sep 30, 2021 | 48,000.00 |
| Sep 30, 2021 | 48,000.00 |
| Jun 30, 2021 | 48,000.00 |
| Jun 30, 2021 | 48,000.00 |